A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation.

Autor: Nakamura Y; Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan., Urakami T; Alivexis, Inc, Tokyo, Japan., Ishimaru K; Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan., Vuong Tran NQ; Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan., Shimizu T; Alivexis, Inc, Tokyo, Japan., Sinko W; Alivexis, Inc, Tokyo, Japan., Takahashi T; Alivexis, Inc, Tokyo, Japan., Marappan S; Aurigene Oncology, Ltd, Bangalore, India., Narayanan K; Aurigene Oncology, Ltd, Bangalore, India., Poddutoori R; Aurigene Oncology, Ltd, Bangalore, India., Terada Y; Alivexis, Inc, Tokyo, Japan., Nakao A; Department of Immunology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.; Yamanashi GLIA Center, University of Yamanashi, Yamanashi, Japan.; Atopy Research Center, Juntendo University School of Medicine, Tokyo, Japan.

Publikováno v: The journal of allergy and clinical immunology. Global [J Allergy Clin Immunol Glob] 2024 Apr 03; Vol. 3 (3), pp. 100249. Date of Electronic Publication: 2024 Apr 03 (Print Publication: 2024).